1De Hert, M, Schreurs, V, Vancampfort, D, Van Winkel, R. Metabolic syndrome in people with schizophrenia: a review. World Psychiatry 2009; 8(1): 15–22.
2Correll, CU, Solmi, M, Veronese, N, Bortolato, B, Rosson, S, Santonastaso, P, et al. Prevalence, incidence and mortality from cardiovascular disease in patients with pooled and specific severe mental illness: a large-scale meta-analysis of 3,211,768 patients and 113,383,368 controls. World Psychiatry 2017; 16(2): 163–80.
4Shiers, D, Bradshaw, T, Campion, J. Health inequalities and psychosis: time for action. Br J Psychiatry 2015; 207(6): 471–3.
5Carney, R, Cotter, J, Bradshaw, T, Firth, J, Yung, AR. Cardiometabolic risk factors in young people at ultra-high risk for psychosis: a systematic review and meta-analysis. Schizophr Res 2016; 170: 290–300.
6Cordes, J, Bechdolf, A, Engelke, C, Kahl, KG, Balijepalli, C, Lösch, C, et al. Prevalence of metabolic syndrome in female and male patients at risk of psychosis. Schizophr Res 2017; 181: 38–42.
7Bresee, LC, Majumdar, SR, Patten, SB, Johnson, JA. Prevalence of cardiovascular risk factors and disease in people with schizophrenia: a population-based study. Schizophr Res 2010; 117(1): 75–82.
8Faulkner, GE, Gorczynski, PF, Cohn, TA. Psychiatric illness and obesity: recognizing the ‘obesogenic’ nature of an inpatient psychiatric setting. Psychiatr Serv 2009; 60(4): 538–41.
9Gorczynski, P, Faulkner, G, Cohn, T. Dissecting the obesogenic environment of a psychiatric setting: client perspectives. Can J Community Ment Health 2013; 32(3): 51–68.
10Eapen, V, Faure-Brac, G, Ward, PB, Hazell, P, Barton, GR, Asghari-Fard, M, et al. Evaluation of weight gain and metabolic parameters among adolescent psychiatric inpatients: role of health promotion and life style intervention programs. J Metabolic Synd 2012; 1: 109.
11Pasha, N, Saeed, S, Drewek, K. Monitoring of physical health parameters for inpatients on a child and adolescent mental health unit receiving regular antipsychotic therapy. BMJ Open Quality 2015; 4(1): u202645.w3700.
12Gnanavel, S, Hussain, S. Audit of physical health monitoring in children and adolescents receiving antipsychotics in neurodevelopmental clinics in Northumberland. World J Psychiatry 2018; 8(1): 27.
13Carney, R, Bradshaw, T, Yung, AR. Monitoring of physical health in services for young people at ultra-high risk of psychosis. Early Intervent Psychiatry 2015; 12: 153–9.
15Greater Manchester West Mental Health NHS Foundation Trust. Physical Health and Wellbeing Policy. Internal NHS report: unpublished; 2011.
16Greater Manchester West Mental Health NHS Foundation Trust. Physical Health Improvement Tool (PHIT). Internal NHS report: unpublished; 2015.
18Jones, RM. Mental Health Act Manual. Thomson/Sweet & Maxwell, 2006.
19Heald, A. Physical health in schizophrenia: a challenge for antipsychotic therapy. Eur Psychiatry 2010; 25: S6–11.
21Vancampfort, D, Rosenbaum, S, Schuch, FB, Ward, PB, Probst, M, Stubbs, B. Prevalence and predictors of treatment dropout from physical activity interventions in schizophrenia: a meta-analysis. Gen Hosp Psychiatry 2016; 39: 15–23.
22Hillsdon, M, Thorogood, M, White, I, Foster, C. Advising people to take more exercise is ineffective: a randomized controlled trial of physical activity promotion in primary care. Int J Epidemiol 2002; 31(4): 808–15.
23Michie, S, Van Stralen, MM, West, R. The behaviour change wheel: a new method for characterising and designing behaviour change interventions. Implement Sci 2011; 6(1): 42.
24Firth, J, Rosenbaum, S, Stubbs, B, Gorczynski, P, Yung, AR, Vancampfort, D. Motivating factors and barriers towards exercise in severe mental illness: a systematic review and meta-analysis. Psychol Med 2016; 46(14): 2869–81.
25Carney, R, Cotter, JC, Bradshaw, T, Yung, AR. Examining the physical health and lifestyle of young people at ultra-high risk for psychosis: a qualitative study involving service users, parents and clinicians. Psychiatry Res 2017; 255: 87–93.
26De Hert, M, Peuskens, J, Sabbe, T, Mitchell, AJ, Stubbs, B, Neven, P, et al. Relationship between prolactin, breast cancer risk, and antipsychotics in patients with schizophrenia: a critical review. Acta Psychiatr Scand 2016; 133(1): 5–22.
27Madhusoodanan, S, Parida, S, Jimenez, C. Hyperprolactinemia associated with psychotropics—a review. Hum Psychopharmacol 2010; 25(4): 281–97.
28Ajmal, A, Joffe, H, Nachtigall, LB. Psychotropic-induced hyperprolactinemia: a clinical review. Psychosomatics 2014; 55(1): 29–36.
29Van Zanten, S, Noel, A, Gresham, L, Boafo, A, Norris, ML, Robinson, A, et al. Sexual health of adolescents admitted to a psychiatric unit. J Pediatr Adolesc Gynecol 2016; 29(2): 174.
30Crawford, MJ, Jayakumar, S, Lemmey, SJ, Zalewska, K, Patel, MX, Cooper, SJ, et al. Assessment and treatment of physical health problems among people with schizophrenia: national cross-sectional study. Br J Psychiatry 2014; 205(6): 473–7.
31Mitchell, AJ, Delaffon, V, Vancampfort, D, Correll, CU, De Hert, M. Guideline concordant monitoring of metabolic risk in people treated with antipsychotic medication: systematic review and meta-analysis of screening practices. Psychol Med 2012; 42(1): 125–47.
32Hayes, C, Palmer, V, Hamilton, B, Simons, C, Hopwood, M. What nonpharmacological therapeutic interventions are provided to adolescents admitted to general mental health inpatient units? A descriptive review. Int J Ment Health Nurs 2019; 28: 671–86.
33Spruit, A, Assink, M, van Vugt, E, van der Put, C, Stams, GJ. The effects of physical activity interventions on psychosocial outcomes in adolescents: a meta-analytic review. Clin Psychol Rev 2016; 45: 56–71.
34Swaby, L, Hind, D, Gossage-Worrall, R, Shiers, D, Mitchell, J, Holt, RI. Adherence to NICE guidance on lifestyle advice for people with schizophrenia: a survey. BJPsych Bull 2017; 41(3): 137–44.